Start an analysis for STZ
Constellation Brands, Inc.
Stock · NYSEProgram summary
| Field | Value | As of | Source |
|---|---|---|---|
| Current authorization | $4.0bn | 31-Aug-26 | 10-Q filed 07-Oct-26 |
| Remaining authorization | $2.6bn | 31-Aug-26 | 10-Q filed 07-Oct-26 |
| Program expiry | 29-Feb-28 | 31-Aug-26 | 10-Q filed 07-Oct-26 |
| Repurchased last quarter | $231m | 31-Aug-26 | 10-Q filed 07-Oct-26 |
| Has used an ASR | No | — |
Programs
| Authorized on | Authorized | Remaining | Expires | Terms |
|---|---|---|---|---|
| Not found in filings | $4.0bn | $2.6bn | 29-Feb-28 | In April 2025, we announced that our Board of Directors authorized the repurchase of up to $4.0 billion of our publicly traded common stock under the 2025 Authorization. The 2025 Authorization expires on February 29, 2028.10-Q filed 07-Oct-26 |
Open-market repurchases
- Jun ’26
- Jul ’26
- Aug ’26
| Month ended | Shares | Avg price | ≈ Value | Source |
|---|---|---|---|---|
| 31-Aug-26 | 181,475 | $131.96 | $24m | 10-Q filed 07-Oct-26 |
| 31-Jul-26 | 808,509 | $132.31 | $107m | 10-Q filed 07-Oct-26 |
| 30-Jun-26 | 714,387 | $139.98 | $100m | 10-Q filed 07-Oct-26 |